Researcher
Oncology Department of Integrated Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, He Fei, Anhui, China.
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 3, 2026 · JOURNAL ARTICLE
International Journal of Medical Sciences
A narrative review synthesizing current knowledge on insulin resistance in pregnancy, its pathogenesis, assessment, and management strategies; provides expert synthesis rather than original evidence of efficacy.
AUG 13, 2026 · JOURNAL ARTICLE
BMC Cancer
A two-phase feasibility and safety study combining dosimetric planning with retrospective clinical validation in a single institution, showing efficiency gain and acceptable acute toxicity, but limited by retrospective design, modest sample size, and surrogate endpoints.
MAY 19, 2026 · JOURNAL ARTICLE
Cell Cycle
This is a mechanistic cell and tissue study demonstrating that UBE2C knockdown suppresses pancreatic cancer cell behavior through PI3K/Akt/mTOR pathway inhibition, with reversal by pathway activator SC79, but lacks clinical trial data, human efficacy endpoints, or effect sizes with confidence intervals.